Tenaya Therapeutics (TNYA) Receivables (2026)
Tenaya Therapeutics (TNYA) posted quarterly Receivables of $10.6 million for Q1 2026.
Tenaya Therapeutics (TNYA) Receivables (2026) Analysis & Trends
Tenaya Therapeutics' Receivables history runs 1 years deep, the most recent figure standing at $10.6 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Tenaya Therapeutics | 155.65 Mn | 155.65 Mn | - | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 371,000.00 |
| Mar 31, 2026 | 10.63 Mn |